Abdullateef Isiaka Alagbonsi1, Toyin Mohammad Salman2, Sheu Oluwadare Sulaiman3,4, Kafayat Anike Adedini2, Susan Kebu2. 1. Department of Clinical Biology (Physiology unit), School of Medicine and Pharmacy, University of Rwanda College of Medicine and Health Sciences, Huye, Rwanda. 2. Department of Physiology, College of Health Sciences, University of Ilorin, Ilorin, Kwara, Nigeria. 3. Department of Physiology, Kampala International University Western Campus, Ishaka Bushenyi, Uganda. 4. Department of Cell Biology, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.
Abstract
BACKGROUND: We investigated the mechanism of artesunate's glucose-modulating effect especially with gender implication. METHODS: Twenty-five (25) male and 25 female rats were separately and blindly allocated into five identical groups (n = 5/group). Group I (control) received 0.2 ml/kg distilled water. Groups II and III both received 2.90 mg/kg artesunate on day one, but 1.45 mg/kg from day two till day five and day fifteen respectively. Groups IV and V both received 8.70 mg/kg artesunate on day one, but 4.35 mg/kg artesunate from day two till day five and day fifteen respectively. RESULTS: In male rats, glucose was reduced by both doses of artesunate at 5 days but increased by high dose at 15 days. Artesunate increased glycogen concentration at short duration which normalised at long duration in both genders. Artesunate increased G6P concentration only in male rats at 15 days but reduced G6Pase activity in male and female rats (except in those that received low and high doses of artesunate for 15 days). Artesunate increased insulin only in male rats treated with low dose artesunate for 5 days. Artesunate increased cortisol concentration in male but reduced it in female rats. Artesunate decreased glucagon concentration except in female rats treated with high dose for 5 days. Artesunate increased oestrogen concentration in male rats that received low dose artesunate for 5 days but reduced it in female rats that received high dose for 15 days. CONCLUSIONS: Artesunate reduces plasma glucose by reducing plasma glucagon concentrations and inhibiting liver glycogenolysis via inhibition of G6Pase activity in both sexes. Increase in insulin concentration contributed to the reduction in blood glucose caused by artesunate in male but not female rats; and artesunate-induced increase in G6P, a substrate for G6PD, could enhance NADPH generation and antioxidant enzyme activation in male rats.
BACKGROUND: We investigated the mechanism of artesunate's glucose-modulating effect especially with gender implication. METHODS: Twenty-five (25) male and 25 female rats were separately and blindly allocated into five identical groups (n = 5/group). Group I (control) received 0.2 ml/kg distilled water. Groups II and III both received 2.90 mg/kg artesunate on day one, but 1.45 mg/kg from day two till day five and day fifteen respectively. Groups IV and V both received 8.70 mg/kg artesunate on day one, but 4.35 mg/kg artesunate from day two till day five and day fifteen respectively. RESULTS: In male rats, glucose was reduced by both doses of artesunate at 5 days but increased by high dose at 15 days. Artesunate increased glycogen concentration at short duration which normalised at long duration in both genders. Artesunate increased G6P concentration only in male rats at 15 days but reduced G6Pase activity in male and female rats (except in those that received low and high doses of artesunate for 15 days). Artesunate increased insulin only in male rats treated with low dose artesunate for 5 days. Artesunate increased cortisol concentration in male but reduced it in female rats. Artesunate decreased glucagon concentration except in female rats treated with high dose for 5 days. Artesunate increased oestrogen concentration in male rats that received low dose artesunate for 5 days but reduced it in female rats that received high dose for 15 days. CONCLUSIONS: Artesunate reduces plasma glucose by reducing plasma glucagon concentrations and inhibiting liver glycogenolysis via inhibition of G6Pase activity in both sexes. Increase in insulin concentration contributed to the reduction in blood glucose caused by artesunate in male but not female rats; and artesunate-induced increase in G6P, a substrate for G6PD, could enhance NADPH generation and antioxidant enzyme activation in male rats.
Authors: Lihua Ye; Morgan A Robertson; Daniel Hesselson; Didier Y R Stainier; Ryan M Anderson Journal: Development Date: 2015-04-15 Impact factor: 6.868
Authors: F Nosten; C Luxemburger; F O ter Kuile; C Woodrow; J P Eh; T Chongsuphajaisiddhi; N J White Journal: J Infect Dis Date: 1994-10 Impact factor: 5.226
Authors: Priya S Kishnani; Stephanie L Austin; Jose E Abdenur; Pamela Arn; Deeksha S Bali; Anne Boney; Wendy K Chung; Aditi I Dagli; David Dale; Dwight Koeberl; Michael J Somers; Stephanie Burns Wechsler; David A Weinstein; Joseph I Wolfsdorf; Michael S Watson Journal: Genet Med Date: 2014-11 Impact factor: 8.822
Authors: Elizabeth A Walker; Adeeba Ahmed; Gareth G Lavery; Jeremy W Tomlinson; So Youn Kim; Mark S Cooper; Jonathan P Ride; Beverly A Hughes; Cedric H L Shackleton; Patrick McKiernan; Elwyn Elias; Janice Y Chou; Paul M Stewart Journal: J Biol Chem Date: 2007-06-22 Impact factor: 5.157